Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Journal of Chemical Information and Modeling|July 27, 2012
Pharmacophore fingerprint-based approach to binding site subpocket similarity and its application to bioisostere replacementDavid J Wood, Jacob de Vlieg, Markus Wagener, et al.Chembiochem : a European Journal of Chemical Biology|February 10, 2009
Crystal structure analysis and in silico pKa calculations suggest strong pKa shifts of ligands as driving force for high-affinity binding to TGTTina Ritschel, Simone Hoertner, Andreas Heine, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|September 12, 2009
High-affinity inhibitors of tRNA-guanine transglycosylase replacing the function of a structural water clusterPhilipp C Kohler, Tina Ritschel, W Bernd Schweizer, et al.Chemmedchem|November 7, 2009
How to replace the residual solvation shell of polar active site residues to achieve nanomolar inhibition of tRNA-guanine transglycosylaseTina Ritschel, Philipp C Kohler, Gerd Neudert, et al.Computational and Structural Biotechnology Journal|April 2, 2014
Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discoveryValère Lounnas, Tina Ritschel, Jan Kelder, et al.Journal of Molecular Biology|July 25, 2009
An integrative approach combining noncovalent mass spectrometry, enzyme kinetics and X-ray crystallography to decipher Tgt protein-protein and protein-RNA interactionTina Ritschel, Cédric Atmanene, Klaus Reuter, et al.Current Opinion in Pharmacology|August 2, 2016
Molecular interaction fingerprint approaches for GPCR drug discoveryMárton Vass, Albert J Kooistra, Tina Ritschel, et al.Molecular Pharmaceutics|September 29, 2015
Statin Lactonization by Uridine 5'-Diphospho-glucuronosyltransferases (UGTs)Tom J J Schirris, Tina Ritschel, Albert Bilos, et al.Acta Crystallographica. Section D, Biological Crystallography|September 4, 2013
High-affinity inhibitors of Zymomonas mobilis tRNA-guanine transglycosylase through convergent optimizationLuzi Jakob Barandun, Florian Immekus, Philipp C Kohler, et al.Plos One|March 3, 2015
Snooker structure-based pharmacophore model explains differences in agonist and blocker binding to bitter receptor hTAS2R39Wibke S U Roland, Marijn P A Sanders, Leo van Buren, et al.Pageof 3